Dr. Harvey graduated in medicine from the University of Melbourne and initially specialised in medical microbiology and infectious diseases. An interest in antibiotic resistance led to a study of antibiotic prescribing and then the forces at work on the pen that writes the ‘script'. This eventually resulted in a move from The Royal Melbourne Hospital to the School of Public Health at La Trobe University where he focused on medicinal drug policy.
Dr. Harvey was a member of the expert group that drafted the World Health Organization “Ethical Criteria for Medicinal Drug Promotion”. He has also been a member of the Commonwealth Pharmaceutical Health and Rational use of Medicines (PHARM) Committee that formulated the Quality Use of Medicines (QUM) pillar of Australian medicines policy.
Dr. Harvey has worked on these issues in SE Asia under a variety of auspices: WHO, AusAID and especially Consumers International (Health Action International Asia Pacific). He was the Australian project director of a $4.0 million, 4 year AusAID program of assistance to the Philippines National Drug Policy and has assisted HAIAP in Malaysia, Indonesia, Sri Lanka, India, Bangladesh, Pakistan, Laos, Vietnam, China, Singapore, Hong Kong and the Philippines. He has also worked as a consultant for the Australian Health Insurance Commission (and USAID) on medicinal drug policy reform in Croatia and Jordan. He has been awarded life membership of Choice (the Australia Consumers' Association) for services to the consumer movement.
In 2016, Dr. Harvey was awarded the Australian and New Zealand Association for the Advancement of Science (ANZAAS) Medal for contribution to science which go beyond normal professional activities.
In 2017, he was made a Member (AM) in the General Division of the Order of Australia, “for significant service to community health and the pharmaceutical industry through roles in developing guidelines for the ethical use of antibiotics".
2016 Australian and New Zealand Association for the Advancement of Science (ANZAAS) Medal